Search by Drug Name or NDC
NDC 50742-0376-04 Buprenorphine 20 ug/h Details
Buprenorphine 20 ug/h
Buprenorphine is a TRANSDERMAL PATCH, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by INGENUS PHARMACEUTICALS, LLC. The primary component is BUPRENORPHINE.
MedlinePlus Drug Summary
Buprenorphine patches are used to relieve severe and persistent pain in people who are expected to need an opioid pain medication around the clock for a long time and who cannot be treated with other medications. Buprenorphine patches should not be used to treat mild or moderate pain, short-term pain, or pain that can be controlled by medication that is taken as needed.It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Related Packages: 50742-0376-04Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Buprenorphine Transdermal Patch
Product Information
| NDC | 50742-0376 |
|---|---|
| Product ID | 50742-376_077f75c7-fa20-9098-e063-6294a90a6700 |
| Associated GPIs | |
| GCN Sequence Number | 059591 |
| GCN Sequence Number Description | buprenorphine PATCH TDWK 20 MCG/HR TRANSDERM |
| HIC3 | H3A |
| HIC3 Description | OPIOID ANALGESICS |
| GCN | 25312 |
| HICL Sequence Number | 023438 |
| HICL Sequence Number Description | BUPRENORPHINE |
| Brand/Generic | Generic |
| Proprietary Name | Buprenorphine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Buprenorphine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | PATCH, EXTENDED RELEASE |
| Route | TRANSDERMAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | ug/h |
| Substance Name | BUPRENORPHINE |
| Labeler Name | INGENUS PHARMACEUTICALS, LLC |
| Pharmaceutical Class | Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA210272 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50742-0376-04 (50742037604)
| NDC Package Code | 50742-376-04 |
|---|---|
| Billing NDC | 50742037604 |
| Package | 4 POUCH in 1 CARTON (50742-376-04) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH |
| Marketing Start Date | 2023-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 74.5122 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | BUPRENORPHINE 20 MCG/HR PATCH |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis